Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

Why this paper is included

Supporting source evidence:

Of those subjects flagging a nutrition and supplement risk, 77.9% of subjects flagged the unhealthy diet risk behavior, 27.9% flagged >2 servings of fish, 25.2% flagged need omega-3 fatty acids, 62.5% flagged no folic acid supplement, 74.0% flagged no iron supplement, 62.1% flagged no calcium supplement, 50.0% flagged no vitamin D supplement, 19.2% flagged vitamin A supplement use, 61.0% flagged other supplement use, and 76.0% flagged caffeine.

Source: Preconception Risk Assessment. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Secondary analysis.

Secondary analysis

Analyses existing study data; this paper is not automatically another independent trial.

Meta-analysis unclear · Blinding unclear / not reported · Human research reported

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

We conducted a secondary analysis of data from a randomized controlled trial designed to study the impact of conversational agent technology in 13 domains of preconception care among 528 non-pregnant African American and Black women.

Source: Abstract.

Participants were recruited using research websites, community programs, and referrals.

Source: Methods.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Using Health Information Technology to Engage African American Women on Nutrition and Supplement Use During the Preconception Period

Secondary analysis · Frontiers in Endocrinology · 2021

Original publication title

Using Health Information Technology to Engage African American Women on Nutrition and Supplement Use During the Preconception Period

Paula Gardiner; Timothy Bickmore; Leanne Yinusa-Nyahkoon; Matthew Reichert; Clevanne Julce; Nireesha Sidduri; Jessica Martin-Howard; Elisabeth Woodhams; Jumana Aryan; Zhe Zhang; Juan Fernandez; Mark Loafman; Jayakanth Srinivasan; Howard Cabral; Brian W. Jack

Copyright © 2021 Gardiner, Bickmore, Yinusa-Nyahkoon, Reichert, Julce, Sidduri, Martin-Howard, Woodhams, Aryan, Zhang, Fernandez, Loafman, Srinivasan, Cabral and Jack

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

Authors’ conclusion

The scalability of Gabby has the potential to improve women’s nutritional health as an adjunct to clinical care or at the population health level. Further studies are needed to determine if improving nutrition and supplement risks can impact clinical outcomes including optimization of weight.

An extract from the source publication. Read it in context.

At a glance

Abstract: What methods does the paper describe?

We conducted a secondary analysis of data from a randomized controlled trial designed to study the impact of conversational agent technology in 13 domains of preconception care among 528 non-pregnant African American and Black women. This analysis is restricted to those 480 women who reported at least one of the ten risks related to nutrition and dietary supplement use.

Source: Methods

Abstract: Importance

Healthy nutrition and appropriate supplementation during preconception have important implications for the health of the mother and newborn. The best way to deliver preconception care to address health risks related to nutrition is unknown.

Source: Importance

Abstract: Interventions

An online conversational agent, called “Gabby”, assesses health risks and delivers 12 months of tailored dialogue for over 100 preconception health risks, including ten nutrition and supplement risks, using behavioral change techniques like shared decision making and motivational interviewing. The control group received a letter listing their preconception risks and encouraging them to talk to a health care provider.

Source: Interventions

Abstract: Results

After 6 months, women using Gabby (a) reported progressing forward on the stage of change scale for, on average, 52.9% (SD, 35.1%) of nutrition and supplement risks compared to 42.9% (SD, 35.4) in the control group (IRR 1.22, 95% CI 1.03 to 1.45, P = 0.019); and (b) reported achieving the action and maintenance stage of change for, on average, 52.8% (SD 37.1) of the nutrition and supplement risks compared to 42.8% (SD, 37.9) in the control group (IRR 1.26, 96% CI 1.08 to 1.48, P = 0.004).

For subjects beginning the study at the contemplation stage of change, intervention subjects reported progressing forward on the stage of change scale for 75.0% (SD, 36.3%) of their health risks compared to 52.1% (SD, 47.1%) in the control group (P = 0.006).

Source: Results

Abstract: Conclusion

The scalability of Gabby has the potential to improve women’s nutritional health as an adjunct to clinical care or at the population health level. Further studies are needed to determine if improving nutrition and supplement risks can impact clinical outcomes including optimization of weight.

Source: Conclusion
Authors’ abstract

Importance

Healthy nutrition and appropriate supplementation during preconception have important implications for the health of the mother and newborn. The best way to deliver preconception care to address health risks related to nutrition is unknown.

Methods

We conducted a secondary analysis of data from a randomized controlled trial designed to study the impact of conversational agent technology in 13 domains of preconception care among 528 non-pregnant African American and Black women. This analysis is restricted to those 480 women who reported at least one of the ten risks related to nutrition and dietary supplement use.

Interventions

An online conversational agent, called “Gabby”, assesses health risks and delivers 12 months of tailored dialogue for over 100 preconception health risks, including ten nutrition and supplement risks, using behavioral change techniques like shared decision making and motivational interviewing. The control group received a letter listing their preconception risks and encouraging them to talk to a health care provider.

Results

After 6 months, women using Gabby (a) reported progressing forward on the stage of change scale for, on average, 52.9% (SD, 35.1%) of nutrition and supplement risks compared to 42.9% (SD, 35.4) in the control group (IRR 1.22, 95% CI 1.03 to 1.45, P = 0.019); and (b) reported achieving the action and maintenance stage of change for, on average, 52.8% (SD 37.1) of the nutrition and supplement risks compared to 42.8% (SD, 37.9) in the control group (IRR 1.26, 96% CI 1.08 to 1.48, P = 0.004).

For subjects beginning the study at the contemplation stage of change, intervention subjects reported progressing forward on the stage of change scale for 75.0% (SD, 36.3%) of their health risks compared to 52.1% (SD, 47.1%) in the control group (P = 0.006).

Conclusion

The scalability of Gabby has the potential to improve women’s nutritional health as an adjunct to clinical care or at the population health level. Further studies are needed to determine if improving nutrition and supplement risks can impact clinical outcomes including optimization of weight.

Clinical Trial Registration

ClinicalTrials.gov, identifier NCT01827215.

Publication and source details

Original title: Using Health Information Technology to Engage African American Women on Nutrition and Supplement Use During the Preconception Period

Paula Gardiner; Timothy Bickmore; Leanne Yinusa-Nyahkoon; Matthew Reichert; Clevanne Julce; Nireesha Sidduri; Jessica Martin-Howard; Elisabeth Woodhams; Jumana Aryan; Zhe Zhang; Juan Fernandez; Mark Loafman; Jayakanth Srinivasan; Howard Cabral; Brian W. Jack

Frontiers in Endocrinology · 2021

Edited by: Qi Chen, The University of Auckland, New Zealand

Reviewed by: Yunhui Tang, Fudan University, China; Settimio D’Andrea, University of L’Aquila, Italy

*Correspondence: Paula Gardiner, Paula.Gardiner@umassmed.edu

This article was submitted to Reproduction, a section of the journal Frontiers in Endocrinology

Copyright © 2021 Gardiner, Bickmore, Yinusa-Nyahkoon, Reichert, Julce, Sidduri, Martin-Howard, Woodhams, Aryan, Zhang, Fernandez, Loafman, Srinivasan, Cabral and Jack2021Gardiner, Bickmore, Yinusa-Nyahkoon, Reichert, Julce, Sidduri, Martin-Howard, Woodhams, Aryan, Zhang, Fernandez, Loafman, Srinivasan, Cabral and Jackhttps://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.National Institute on Minority Health and Health Disparities10.13039/100006545

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-12T13:34:49.581141+00:00

DOI: 10.3389/fendo.2020.571705 · PMC7874041